Evidence map›Paper›PMID 19176555›Full record

ArticleBioinformatics (Oxford, England)2009

A flexible rank-based framework for detecting copy number aberrations from array data.

Thomas LaFramboise, Wendy Winckler, Roman K Thomas

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas LaFramboiseDepartment of Genetics, Case Western Reserve University, Cleveland, OH 44106, USA. Thomas.LaFramboise@case.edu
Wendy Winckler
Roman K Thomas

Funding

A genomic survey of allele-specific selection in tumor ampliconsR01CA131341 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LAFRAMBOISE, THOMAS LOUIS, PE'ER, ITSHACK G · 2008 to 2011
$1.2M
NCI NIH HHS R01 CA131341
6 · The paper itself

Abstract

motivationDNA copy number aberration--both inherited and sporadic--is a significant contributor to a variety of human diseases. Copy number characterization is therefore an area of intense research. Probe hybridization-based arrays are important tools used to measure copy number in a high-throughput manner.

resultsIn this article, we present a simple but powerful nonparametric rank-based approach to detect deletions and gains from raw array copy number measurements. We use three different rank-based statistics to detect three separate molecular phenomena-somatic lesions, germline deletions and germline gains. The approach is robust and rigorously grounded in statistical theory, thereby enabling the meaningful assignment of statistical significance to each putative aberration. We demonstrate the flexibility of our approach by applying it to data from three different array platforms. We show that our method compares favorably with established approaches by applying it to published well-characterized samples. Power simulations demonstrate exquisite sensitivity for array data of reasonable quality.

conclusionsOur flexible rank-based framework is suitable for multiple platforms including single nucleotide polymorphism arrays and array comparative genomic hybridization, and can reliably detect gains or losses of genomic DNA, whether inherited, de novo, or somatic. AVAILABILITY: An R package RankCopy containing the methods described here, and is freely available from the author's web site (http://mendel.gene.cwru.edu/laframboiselab/). SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Genetic VariationOligonucleotide Array Sequence AnalysisAutistic DisorderComputational BiologyDNAGene DosageGenomeHumansNeoplasmsDNA

Identifiers

PMID19176555
PMCPMC2732300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.